These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22896673)

  • 21. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics.
    Lysaght MJ; Jaklenec A; Deweerd E
    Tissue Eng Part A; 2008 Feb; 14(2):305-15. PubMed ID: 18333783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In the Spotlight: Tissue and Molecular Engineering.
    Desai TA
    IEEE Rev Biomed Eng; 2008; 1():21-2. PubMed ID: 22274897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically modified cells in regenerative medicine and tissue engineering.
    Sheyn D; Mizrahi O; Benjamin S; Gazit Z; Pelled G; Gazit D
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):683-98. PubMed ID: 20114067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platform technologies for tubular organ regeneration.
    Basu J; Ludlow JW
    Trends Biotechnol; 2010 Oct; 28(10):526-33. PubMed ID: 20800302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent applications of regenerative medicine to urologic structures and related tissues.
    Atala A
    Curr Opin Urol; 2006 Jul; 16(4):305-9. PubMed ID: 16770133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of endogenous regenerative technology for in situ regenerative medicine.
    Anitua E; Sánchez M; Orive G
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):741-52. PubMed ID: 20102730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of biologics in cardiovascular regenerative medicine.
    Bartunek J; Sherman W; Vanderheyden M; Fernandez-Aviles F; Wijns W; Terzic A
    Clin Pharmacol Ther; 2009 May; 85(5):548-52. PubMed ID: 19212313
    [No Abstract]   [Full Text] [Related]  

  • 28. Rational design and protein engineering of growth factors for regenerative medicine and tissue engineering.
    Moss AJ; Sharma S; Brindle NP
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):717-21. PubMed ID: 19614582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction to regenerative medicine and tissue engineering.
    Stoltz JF; Decot V; Huseltein C; He X; Zhang L; Magdalou J; Li YP; Menu P; Li N; Wang YY; de Isla N; Bensoussan D
    Biomed Mater Eng; 2012; 22(1-3):3-16. PubMed ID: 22766697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Regenerative Medicine Products.
    Gee AP
    Adv Exp Med Biol; 2018; 1098():189-198. PubMed ID: 30238372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoscale surfacing for regenerative medicine.
    Yang Y; Leong KW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):478-95. PubMed ID: 20803682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regenerative medicine: the next frontier.
    Kwan MD; Longaker MT
    Transplantation; 2008 Jul; 86(2):206-7. PubMed ID: 18645480
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospects for translational regenerative medicine.
    Chen FM; Zhao YM; Jin Y; Shi S
    Biotechnol Adv; 2012; 30(3):658-72. PubMed ID: 22138411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regenerative engineering.
    Laurencin CT; Khan Y
    Sci Transl Med; 2012 Nov; 4(160):160ed9. PubMed ID: 23152324
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergies of microtissue design, viral transduction and adjustable transgene expression for regenerative medicine.
    Kelm JM; Kramer BP; Gonzalez-Nicolini V; Ley B; Fussenegger M
    Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):3-16. PubMed ID: 12968952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Care of rodent models used for preclinical evaluation of tissue-engineered/regenerative medicine product candidates.
    Mihalko KL
    Methods Mol Biol; 2013; 1001():197-206. PubMed ID: 23494431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Technological aspects of regenerative medicine and tissue engineering of articular cartilage].
    Pörtner R; Meenen NM
    Handchir Mikrochir Plast Chir; 2010 Dec; 42(6):329-36. PubMed ID: 20480456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Important contribution and necessity of stem cells scaffolds for regenerative medicine and the therapeutic applications].
    Tabata Y
    Nihon Rinsho; 2008 May; 66(5):881-6. PubMed ID: 18464505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The design and use of animal models for translational research in bone tissue engineering and regenerative medicine.
    Muschler GF; Raut VP; Patterson TE; Wenke JC; Hollinger JO
    Tissue Eng Part B Rev; 2010 Feb; 16(1):123-45. PubMed ID: 19891542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scaffold-free cell delivery for use in regenerative medicine.
    Kelm JM; Fussenegger M
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):753-64. PubMed ID: 20153387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.